The patient is a 61-year-old male who was admitted to the hospital for surgery. He has a history of hypertension, hyperlipidemia, and type 2 diabetes mellitus. His blood pressure is usually well-controlled on lisinopril, and his cholesterol is maintained on atorvastatin. He takes metformin for his diabetes and his blood glucose levels are usually within target range.

The patient has a history of smoking but has quit for the past 5 years. He denies any history of lung disease and has no symptoms of chronic cough or shortness of breath. His lung function tests were normal on previous evaluations.

Regarding his cardiovascular health, the patient has no prior history of myocardial infarction or angina. He does not complain of chest pain or palpitations. He has a regular exercise routine and no limitations in his daily activities.

On review of systems, the patient denies any gastrointestinal problems such as reflux, ulcers, or bleeding. He has no history of liver disease or abnormal liver function tests. His bowel movements are regular, and he denies any abdominal pain or changes in appetite.

The patient has well-controlled blood glucose levels with an HbA1c of 6.7%. He does not have a history of diabetic neuropathy or retinopathy. He denies any symptoms of peripheral vascular disease, such as leg pain or numbness.

In terms of surgical history, the patient underwent cholecystectomy 10 years ago due to symptomatic cholelithiasis. He tolerated the surgery well and had an uneventful postoperative recovery.

The patient's family history is significant for hypertension and diabetes. His father had a myocardial infarction at the age of 69, but there is no history of any other cardiac diseases in the family.

During the preoperative evaluation, the patient's physical examination was within normal limits. His vital signs were stable, and he had no signs of dehydration or malnutrition.

Laboratory tests revealed normal kidney function, with a serum creatinine of 0.9 mg/dL. The patient's liver function tests were also normal, as were his complete blood count and coagulation profile.

The patient was advised to discontinue his atorvastatin and metformin temporarily before surgery. He was also instructed to avoid food and drinks for at least 8 hours before the scheduled procedure.

Postoperatively, the patient had an unremarkable recovery. He was closely monitored for pain control and was able to tolerate an oral diet within a few hours after surgery. His vital signs remained stable, and there were no signs of wound infection or hematoma formation.

Despite the surgical stress, the patient's blood glucose levels remained within acceptable range without the need for insulin. His lisinopril was restarted on postoperative day 1, and he did not experience any significant blood pressure fluctuations.

The patient's chest X-ray performed on the first postoperative day showed clear lung fields with no evidence of atelectasis or infiltrates. His oxygen saturation remained above 95% on room air.

Overall, the patient had a smooth postoperative course without any complications. He was discharged home on postoperative day 2 and advised to continue his regular medications and follow up with his primary care physician in two weeks.